Yu Rong of Meinian Onehealth: AI Empowering Health Management and Longevity Technology

Deep News17:50

Special Topic: 2026 Sustainable Global Leaders Conference & the Second Green Industry and Sustainable Consumption Expo. The "2026 Sustainable Global Leaders Conference" was held in Shanghai from October 20 to 22. Yu Rong, Chairman of Meinian Onehealth Healthcare Holdings Co., Ltd., attended and delivered a speech titled "AI Empowering Health Management and Longevity Technology."

Speaking about industry trends and Meinian's strategy, Yu Rong pointed out that under the AI wave, giants such as Anthropic and OpenAI are comprehensively positioning themselves in the life sciences industry, and there is a global trend of accelerating and increasing investment in this field. What is the logic behind these AI giants' comprehensive layout in the life and health sector? In Yu Rong's view, "longevity medicine" and "longevity technology" are precisely the main battlefield of the next round of AI competition. Behind this, in addition to the enormous consumer market, there are rapidly improving AI capabilities, the ability to process health data, and the thriving development trends of the life science industry and the health consumption industry. As a result, it can be seen that the big health industry is facing major development opportunities.

Yu Rong believes that the core of health checkups and preventive medicine has shifted from traditional disease screening to proactive life and health management, or life asset management and longevity asset management. This is a major transformation in the industry's development philosophy and a comprehensive upgrade of the industry's future development philosophy. From Meinian's own practice, through more than 20 years of cultivation, Meinian has accumulated health checkup data from 240 million people, serving 30 million people annually, and is building a health infrastructure foundation. It can be seen that the industry's development is rapidly evolving along AI-driven, data-driven, and service-driven lines.

Specifically regarding longevity technology and health management, Yu Rong believes that in the future, a continuous health management closed loop will be built through AI + proactive monitoring + smart hardware + continuous health management + AI agents. Based on the above analysis, Meinian has jointly developed products such as an AI model for multi-cancer early screening with Alibaba DAMO Academy, as well as a digital doctor for personalized, full-process, digitalized services that can provide long-cycle private health butler services. In terms of longevity engineering, Meinian has built a complete closed loop from biological age detection models to regeneration and intervention, making longevity medical engineering an important carrier in the future field of medical innovation.

Yu Rong also mentioned that this year Meinian comprehensively launched AI aging product assessments, biological clock assessments, etc., providing very valuable data support and an important disciplinary research carrier for aging research. At the same time, based on precise biological clock age evaluation, it provides one-stop precise and personalized anti-aging solutions. Yu Rong finally emphasized that under the AI-driven era wave, doing a good job in life asset management and longevity technology management, while building large-scale life and health infrastructure, to provide long-term infrastructure and service guarantees for the country's public health policies and residents' health management, is an important responsibility that a leading enterprise in preventive medicine should fulfill.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment